tiprankstipranks
Trending News
More News >
Imax Corp. (IMAX)
NYSE:IMAX

IMAX (IMAX) AI Stock Analysis

Compare
641 Followers

Top Page

IMAX

IMAX

(NYSE:IMAX)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
,
Outperform 73 (OpenAI - 5.2)
,
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
$42.00
▲(12.12% Upside)
Action:ReiteratedDate:02/26/26
The score is driven primarily by improved financial performance (strong recent profitability and cash flow) and a very bullish earnings outlook with ambitious margin and growth targets. Technicals are mildly supportive but not strongly momentum-driven, while the high P/E meaningfully reduces the overall score.
Positive Factors
Improved Profitability and Margins
Sustained high gross and improved net margins materially increase durable free cash generation and return on invested capital. Higher margins provide structural capacity to fund system installs, content partnerships and margin expansion targets, reducing sensitivity to modest revenue dips.
Stronger Cash Generation and Conversion
Consistent positive operating and free cash flow with improved conversion strengthens liquidity and self-funding ability for network expansion. Reliable cash generation supports deleveraging, R&D and marketing investments, making long-term growth targets more attainable without heavy external financing.
Network Expansion and Strategic Partnerships
Ongoing system installs, signed upgrade agreements and distribution wins (e.g., streaming/sports partnerships) build a durable competitive moat: larger footprint drives higher box‑office share, better studio leverage and recurring JV revenues, underpinning mid‑term revenue and margin targets.
Negative Factors
Material Absolute Debt Load
Although leverage has improved, a still‑material absolute debt balance limits financial flexibility if box office or content timing weakens. Debt servicing and covenant sensitivity could constrain capital allocation and raise refinancing risk in adverse cycles, pressuring strategic optionality.
Slate Concentration and China Timing Volatility
Revenue and cash flow are structurally lumpy due to dependence on blockbuster release timing and regional windows. Delays or concentrated slates—especially in China—create multi-quarter swings that complicate forecasting, working capital and consistent margin realization over the medium term.
Limited Control Over Ticket Pricing
Earnings tied to exhibitor pricing and revenue-share restrict IMAX's direct ability to capture incremental ticket premium. This structural dependence reduces margin levers and monetization control, making sustained per‑screen revenue growth contingent on partner willingness and broader industry pricing dynamics.

IMAX (IMAX) vs. SPDR S&P 500 ETF (SPY)

IMAX Business Overview & Revenue Model

Company DescriptionIMAX Corporation, together with its subsidiaries, operates as an entertainment technology company worldwide. It offers cinematic solution through proprietary software, theater architecture, intellectual property, and specialized equipment. The company offers IMAX Digital Re-Mastering (DMR), a proprietary technology that digitally enhances the image resolution, visual clarity, and sound quality of motion picture films for projection on IMAX screens; IMAX theater systems to exhibitor customers through sales, leases, and joint revenue sharing arrangements; and digital projection systems. It also provides preventative and emergency maintenance services to IMAX network; distributes large-format documentary films; film post-production and quality control services for large-format films, and digital post-production services; owns and operates IMAX theaters; and rents 2D and 3D large-format film and digital cameras, as well as offers production advice and technical assistance services to documentary and Hollywood filmmakers. The company markets its theater systems through a direct sales force and marketing staff to science and natural history museums, zoos, aquaria, and other educational and cultural centers, as well as theme parks, private home theaters, tourist destination sites, fairs, and expositions. It owns or otherwise has rights to trademarks and trade names, which include IMAX, IMAX Dome, IMAX 3D, IMAX 3D Dome, Experience It in IMAX, The IMAX Experience, An IMAX Experience, An IMAX 3D Experience, IMAX DMR, DMR, IMAX Enhanced, IMAX nXos, and Films To The Fullest. As of December 31, 2021, the company had a network of 1,683 IMAX theater systems comprising 1,599 commercial multiplexes, 12 commercial destinations, and 72 institutional facilities operating in 87 countries and territories. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada.
How the Company Makes MoneyIMAX primarily generates revenue through a combination of technology-based fees and content-based participation tied to the IMAX theatrical ecosystem. Key revenue streams include: (1) Theater system and services revenue: IMAX sells or leases its projection and audio systems and may earn ongoing service, maintenance, and support fees tied to installed systems. These arrangements can include installation, monitoring, and equipment-related services provided to exhibitor partners. (2) Joint revenue sharing arrangements (JRSA) and other exhibitor agreements: For many IMAX-branded auditoriums, IMAX partners with exhibitors under agreements where IMAX earns a percentage of box office receipts (and/or other economics) from IMAX screenings rather than (or in addition to) upfront equipment sales, aligning IMAX’s earnings with theater performance. (3) Content distribution and studio-related revenue: IMAX earns fees associated with making films available in the IMAX format and for IMAX bookings, which can include revenue-sharing or royalty-like participation linked to the IMAX box office performance of a title. (4) Other revenue sources: IMAX can earn income from licensing the IMAX brand/technology and from ancillary services related to theater network support and quality assurance. Significant factors influencing earnings include the size and performance of the global IMAX theater network, box office demand for IMAX showings (which depends on film slate strength and consumer attendance), and relationships with major exhibitors and film studios to secure IMAX releases and screen allocations.

IMAX Earnings Call Summary

Earnings Call Date:Feb 25, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 23, 2026
Earnings Call Sentiment Positive
The call presented overwhelmingly positive operational and financial momentum: record box office, revenue, margins, EPS and cash flow, strong network growth and a deep multi-year content slate underpinning ambitious margin and growth targets. The principal negatives were limited, one-time charges and strategic repositioning costs, a higher tax rate, timing volatility in China, and dependency on exhibitors for pricing and rights complexity for alternative/live content. On balance the highlights materially outweigh the lowlights and management articulated clear plans and strong liquidity to capitalize on the opportunity.
Q4-2025 Updates
Positive Updates
Record Global Box Office and Market Share
Global box office of $1.28 billion in 2025, up 40% year-over-year; captured a record 3.8% of global box office, up 700 basis points YoY.
Record Revenue and Profitability
Full year revenue of $410 million, up 16% vs 2024; adjusted EBITDA of $185 million (full year), up 33% YoY; adjusted EBITDA margin of 45% (record, up ~570 bps YoY).
Adjusted EPS and Cash Flow Strength
Adjusted EPS of $1.45, up $0.50 year-over-year; record cash from operations of $127 million; full year free cash flow of $85 million and adjusted EBITDA conversion of 46% (61% excluding network investment).
Content Performance and Awards
Local-language films grossed $405 million worldwide (67 international releases); IMAX releases earned 58 Academy Award nominations; Content Solutions revenue growth (Q4 +50% YoY) and full year content gross profit of $100 million (50% YoY growth) with a 66% content gross margin (up ~1,260 bps YoY).
Network Expansion and System Growth
160 systems installed in 2025 (high end of guidance), up ~10% YoY; 166 new/upgraded system agreements (signings) in 2025, up 28% YoY; commercial footprint growth of 3.5% overall with domestic +4% and rest-of-world just over +8% (record 118 systems installed in certain markets).
Strong Balance Sheet and Liquidity Actions
Year-end cash $151 million (up 50% YoY), debt $289 million with net leverage 0.7x; renewed/expanded $375 million revolving credit facility; issued $250 million convertible notes at 0.75% and implemented a capped call effectively raising conversion price to $57.
Compelling Forward Guidance and Slate
2026 outlook: projected $1.4 billion box office, 160–175 system installs, adjusted EBITDA margin mid-40s with a 45% floor; multi-year targets include revenue CAGR high single to low double digits through 2028 and >50% adjusted EBITDA margin by 2028; strong multi-year film pipeline (Nolan's Odyssey, Mandalorian, Dune Part Three, Project Hail Mary, Super Mario, Toy Story 5, multiple 2027/2028 mega titles) and 60% of 2027 already booked.
Product and Distribution Wins
Apple partnership to stream Formula 1 races to IMAX locations (U.S. launch with international expansion being explored); exclusive openings (e.g., Elvis Doc EPiC); continued traction with filmmakers and studios (multiple films shot with IMAX cameras).
Negative Updates
Q4 One-Time Charges and Goodwill Impairment
Included $22 million of one-time Q4 charges: $15 million for strategic repurchase of convertible notes due 2026 and $7 million non-cash goodwill impairment related to legacy SSIMWAVE business.
Higher Effective Tax Rate
2025 tax rate of 28% vs 13% in 2024, representing a year-over-year headwind of approximately $0.16 per share and reducing EPS comparability.
Repositioning Costs and SSIMWAVE Impacts
Non-cash impairment and ongoing repositioning/optimization of the streaming and consumer technology (SSIMWAVE) business indicate transition costs and near-term write-downs while focusing back on core business.
China Timing and Slate Concentration Risk
Chinese New Year period described as a 'B slate' with several local titles delayed into summer, creating timing-driven volatility (2025 saw 46% of China box office in Q1) and sensitivity to release timing in Greater China.
Limited Control Over Exhibitor Pricing
IMAX does not set ticket prices—exhibitor partners do—so upside from potential price increases is dependent on exhibitors' willingness to test premiums; pricing execution is therefore out of IMAX's direct control.
Complexity and Cost of Expanding Alternative/Live Sports Content
Live sports and alternative content opportunities (e.g., World Cup, additional F1 rights) face complex, expensive rights negotiations; expansion will require careful modeling and may be constrained by rights costs and delivery complexity.
Company Guidance
IMAX guided to a strong 2026 with a projected $1.4 billion in global box office, 160–175 system installations worldwide (targeting a ~45%/55% sales-to-JV mix), and total adjusted EBITDA margin in the mid‑40s with a floor of 45%; looking further out through 2028, management expects revenue growth at a high‑single to low‑double digit CAGR, adjusted EBITDA margin above 50% by 2028, adjusted EPS to grow at roughly twice the rate of revenue, and free cash flow conversion of about 50% in 2026 and rising—they also noted Q1 is expected to be the lowest box office quarter and the company is ~60% booked for 2027.

IMAX Financial Statement Overview

Summary
Financials show a clear step-up: strong profitability (gross margin ~60%, net margin ~20%) and solid recent free cash flow with improved cash conversion. Offsetting factors are uneven revenue growth across years and a still-material (though improving) debt position.
Income Statement
78
Positive
Profitability has strengthened materially: the latest annual period shows solid gross margin (~60%) and a much-improved net margin (~20%) versus low-to-mid single digits in 2023–2024 and losses in 2020–2022. Revenue rebounded over the cycle (strong growth in 2021 and 2023, modest growth in 2025), though growth has been uneven with a decline in 2024. Overall, earnings momentum is a clear positive, but the top-line trajectory is not consistently stable year-to-year.
Balance Sheet
66
Positive
Leverage appears manageable but not light. Debt-to-equity improved to ~0.72 in the latest annual period (down from ~0.93–1.00 in 2022–2024), and equity has grown versus 2022–2024. Returns on equity improved meaningfully (about 24% most recently), reflecting better profitability. Key watchouts are the still meaningful absolute debt load and the fact leverage was higher in recent history, suggesting sensitivity if operating conditions weaken.
Cash Flow
75
Positive
Cash generation is a notable strength in the latest annual period: operating cash flow (~$127M) and free cash flow (~$119M) are both strong, with sharp free cash flow growth (~30%) versus the prior year. Cash conversion improved substantially, with free cash flow close to net income (about 0.94x), compared with weaker conversion in 2023–2024 and negative free cash flow in 2021–2022. The main risk is cyclicality—cash flow performance has been volatile over the broader period.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue410.21M352.21M374.84M300.81M254.88M
Gross Profit237.57M190.20M214.34M156.35M134.41M
EBITDA133.10M111.28M112.96M52.77M74.16M
Net Income34.88M26.06M25.34M-22.80M-22.33M
Balance Sheet
Total Assets894.03M830.40M814.67M821.15M883.25M
Cash, Cash Equivalents and Short-Term Investments151.17M100.59M76.20M97.40M189.71M
Total Debt297.41M278.12M252.06M263.02M226.11M
Total Liabilities466.30M452.18M469.08M491.39M452.88M
Stockholders Equity337.89M299.47M273.14M263.36M356.08M
Cash Flow
Free Cash Flow118.90M29.62M25.78M-15.30M-11.71M
Operating Cash Flow127.07M70.84M58.62M17.32M6.07M
Investing Cash Flow-41.92M-41.22M-31.79M-53.29M-7.00K
Financing Cash Flow-34.08M-6.04M-48.53M-58.51M-132.72M

IMAX Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price37.46
Price Trends
50DMA
37.13
Positive
100DMA
36.44
Positive
200DMA
32.67
Positive
Market Momentum
MACD
0.37
Positive
RSI
44.37
Neutral
STOCH
25.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IMAX, the sentiment is Neutral. The current price of 37.46 is below the 20-day moving average (MA) of 39.35, above the 50-day MA of 37.13, and above the 200-day MA of 32.67, indicating a neutral trend. The MACD of 0.37 indicates Positive momentum. The RSI at 44.37 is Neutral, neither overbought nor oversold. The STOCH value of 25.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IMAX.

IMAX Risk Analysis

IMAX disclosed 30 risk factors in its most recent earnings report. IMAX reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

IMAX Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$2.02B56.8410.67%9.30%67.19%
65
Neutral
$2.69B6.89-618.85%0.68%-80.73%
61
Neutral
$3.08B19.4425.84%1.45%9.70%-31.62%
61
Neutral
$3.92B13.101.51%24.54%-119.75%
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
51
Neutral
$2.75B-14.3320.86%97.19%-21.46%
44
Neutral
$569.11M-1.2735.45%9.74%12.29%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IMAX
IMAX
36.62
10.13
38.24%
CNK
Cinemark Holdings
26.37
0.25
0.97%
AMC
AMC Entertainment
1.03
-1.96
-65.55%
SPHR
Sphere Entertainment
112.88
80.66
250.34%
LION
Lionsgate Studios
9.53
1.34
16.36%
MSGE
Madison Square Garden Entertainment Corp.
57.38
23.36
68.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 26, 2026